Discover verified cancer discoveries

Search and filter stories that passed editorial review. Evidence strength, regulatory status, and guideline position are shown separately and are never inferred from one another.

Filter discoveries

Results

Active filters:

Cancer type: Other / Rare Cancers Remove Cancer type filter
Regulatory status: FDA-approved for the exact stated cancer/use Remove Regulatory status filter

Clear all

1 verified discovery matches your filters.

FDA approves zanidatamab for HER2-positive biliary tract cancer, including cholangiocarcinoma

Later-Stage HumanFDA Approved

Cancer type: Other / Rare Cancers
Published: August 13, 2026

In cohort 1 of the single-arm, phase 2b HERIZON-BTC-01 trial, zanidatamab -- a bispecific antibody that binds two separate sites on the HER2 protein -- produced a confirmed objective response…

Primary source cited

Last reviewed 2026-08-13